Marshall Wace Asia’s Amgen AMGN Stock Holding History

Marshall Wace Asia’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-98	Closed	-$24K	–	126
2019 Q4	$24K	Buy	+98	New	+$21.6K	﹤0.01%	131

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace Asia's AMGN Position: Q1 2020 in Review

Marshall Wace Asia sold out of Amgen (AMGN) in Q1 2020, closing a stake of 98 shares — an estimated $24K sold.

Marshall Wace Asia first reported a position in AMGN in Q4 2019 and held it in 1 quarter. The position peaked at $24K in Q4 2019. 2,030 funds tracked by Wall St. Rank hold AMGN as of Q1 2020.

Marshall Wace Asia reported no remaining Amgen position as of Q1 2020 after selling out during the quarter.
Marshall Wace Asia sold 98 Amgen shares in Q1 2020, an estimated $24K.
Marshall Wace Asia first reported a position in Amgen in Q4 2019 and held it in 1 quarter.
Marshall Wace Asia's Amgen position peaked at $24K in Q4 2019.
2,030 funds tracked by Wall St. Rank held Amgen as of Q1 2020.

Based on Marshall Wace Asia's 13F filing for Q1 2020, filed 15 May 2020.